Effect of Intraoperative Dexamethasone on Post-op Dry Eye
Study Details
Study Description
Brief Summary
To compare the signs and symptoms of dry eye after cataract surgery between subjects randomized to receive intraoperative dexamethasone in addition to the use of a standard topical post-op treatment regimen.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 4 |
Detailed Description
Forty patients requiring cataract surgery will be randomized to treatment of post-operative inflammation with a single intraoperative dexamethasone injection plus a standard course of topical ophthalmic corticosteroid drops or the standard treatment alone. Dry eye testing will be administered at baseline, 1 week and 3 weeks following surgery.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Intracameral dexamethasone 9% + postoperative topical prednisolone acetate dexamethasone intraocular suspension, 9% injected intracamerally at the time of cataract surgery + topical ophthalmic prednisolone acetate for 3 weeks post-operatively |
Drug: dexamethasone intraocular suspension, 9%
single dose intracameral corticosteroid
Other Names:
Drug: Prednisolone Acetate 1% Oph Susp
topical ophthalmic steroid drop
|
Active Comparator: postoperative topical prednisolone acetate topical ophthalmic prednisolone acetate for 3 weeks post-operatively |
Drug: Prednisolone Acetate 1% Oph Susp
topical ophthalmic steroid drop
|
Outcome Measures
Primary Outcome Measures
- Evaluation of Intraoperative Use of Dexycu on Tear Film Osmolarity at 3 Weeks Postoperatively [3 weeks]
Tear Film Osmolarity as measured on Tear Lab system; validated measure of Tear Film Osmolarity Osmolarity was reported in milliosmoles per liter (mOsmol/L)
Eligibility Criteria
Criteria
Inclusion Criteria:
- undergoing bilateral cataract surgery
Exclusion Criteria:
- central corneal staining with fluorescein and/or a tear film osmolarity of greater than 340 in either eye
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Hauser Ross Surgical Center | Sycamore | Illinois | United States | 60178 |
Sponsors and Collaborators
- SR Cornea Consultants
Investigators
- Principal Investigator: Sanjay Rao, MD, SR Cornea Conslutants
Study Documents (Full-Text)
More Information
Publications
None provided.- SRCC10
Study Results
Participant Flow
Recruitment Details | patients scheduled to undergo bilateral cataract surgery 40 participants were enrolled, each eye was randomized to 2 different treatment groups (intracameral dexamethasone + postoperative topical prednisolone or postoperative topical prednisolone alone) |
---|---|
Pre-assignment Detail | patients scheduled to undergo bilateral cataract surgery were randomly assigned to receive an intracameral injection of dexamethasone + a standard postoperative topical steroid regimen in one eye, and a standard postoperative topical steroid regimen in the other eye. Preoperative and postoperative signs of dry eye were compared between the two groups |
Arm/Group Title | Intracameral Dexamethasone + Postoperative Topical Prednisolone | Postoperative Topical Prednisolone |
---|---|---|
Arm/Group Description | dexamethasone intraocular suspension, 9% + topical ophthalmic prednisolone dexamethasone intraocular suspension, 9%: single dose intracameral corticosteroid Prednisolone Acetate: topical ophthalmic drop for 3 weeks | postoperative topical prednisolone for 3 weeks |
Period Title: Overall Study | ||
STARTED | 40 | 40 |
3 Week Tear Film Osmolarity Testing | 40 | 40 |
COMPLETED | 40 | 40 |
NOT COMPLETED | 0 | 0 |
Baseline Characteristics
Arm/Group Title | Intracameral Dexamethasone + Post-operative Topical Prednisolone | Post-operative Topical Prednisolone | Total |
---|---|---|---|
Arm/Group Description | dexamethasone intraocular suspension, 9% + topical ophthalmic prednisolone dexamethasone intraocular suspension, 9%: single dose intracameral corticosteroid Prednisolone Acetate: topical ophthalmic drop | topical ophthalmic prednisolone acetate Prednisolone Acetate: topical ophthalmic drop | Total of all reporting groups |
Overall Participants | 40 | 40 | 40 |
Overall eyes | 40 | 40 | 80 |
Age (eyes) [Count of Units] | |||
<=18 years |
1
|
1
|
2
|
Between 18 and 65 years |
15
|
15
|
30
|
>=65 years |
24
|
24
|
48
|
Age (years) [Mean (Standard Deviation) ] | |||
Mean (Standard Deviation) [years] |
67.49
(10.42)
|
67.49
(10.42)
|
67.49
(10.42)
|
Sex: Female, Male (eyes) [Count of Units] | |||
Female |
22
|
22
|
44
|
Male |
18
|
18
|
36
|
Race and Ethnicity Not Collected (Count of Participants) | |||
Count of Participants [Participants] |
0
0%
|
||
Region of Enrollment (eyes) [Number] | |||
United States |
40
|
40
|
80
|
Preoperative Tear Film Osmolarity (mOsmo/L) [Mean (Full Range) ] | |||
Mean (Full Range) [mOsmo/L] |
307.475
|
307.775
|
307.625
|
Outcome Measures
Title | Evaluation of Intraoperative Use of Dexycu on Tear Film Osmolarity at 3 Weeks Postoperatively |
---|---|
Description | Tear Film Osmolarity as measured on Tear Lab system; validated measure of Tear Film Osmolarity Osmolarity was reported in milliosmoles per liter (mOsmol/L) |
Time Frame | 3 weeks |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Intracameral Dexamethasone | Postoperative Prednisolone Acetate |
---|---|---|
Arm/Group Description | intracameral dexamethasone + postoperative prednisolone acetate for 3 weeks | postoperative prednisolone acetate for 3 weeks |
Measure Participants | 40 | 40 |
Measure eyes | 40 | 40 |
Mean (95% Confidence Interval) [mOsmol/L] |
311.15
|
316.3
|
Statistical Analysis 1
Statistical Analysis Overview | Comparison Group Selection | Intracameral Dexamethasone |
---|---|---|
Comments | ||
Type of Statistical Test | Superiority | |
Comments | ||
Statistical Test of Hypothesis | p-Value | <.01 |
Comments | ||
Method | ANOVA | |
Comments | ||
Method of Estimation | Estimation Parameter | F-Statistic |
Estimated Value | 207.4 | |
Confidence Interval |
(2-Sided) % to |
|
Parameter Dispersion |
Type: Value: |
|
Estimation Comments |
Adverse Events
Time Frame | 3 months | |||
---|---|---|---|---|
Adverse Event Reporting Description | ||||
Arm/Group Title | Intracameral Dexamethasone + Postoperative Prednisolone Acetate | Postoperative Prednisolone Acetate Regimen | ||
Arm/Group Description | intracameral dexamethasone 9% injection at the time of cataract surgery + standard postoperative prednisolone acetate regimen | standard postoperative prednisolone acetate regimen | ||
All Cause Mortality |
||||
Intracameral Dexamethasone + Postoperative Prednisolone Acetate | Postoperative Prednisolone Acetate Regimen | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/40 (0%) | 0/40 (0%) | ||
Serious Adverse Events |
||||
Intracameral Dexamethasone + Postoperative Prednisolone Acetate | Postoperative Prednisolone Acetate Regimen | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/40 (0%) | 0/40 (0%) | ||
Other (Not Including Serious) Adverse Events |
||||
Intracameral Dexamethasone + Postoperative Prednisolone Acetate | Postoperative Prednisolone Acetate Regimen | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/40 (0%) | 0/40 (0%) |
Limitations/Caveats
More Information
Certain Agreements
Principal Investigators are NOT employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Dr. Sanjay Rao |
---|---|
Organization | SR Cornea Consultants |
Phone | 8476685498 |
sanjaynraomd@gmail.com |
- SRCC10